Expanding Your Footprint as a Pharmacy Owner
Drug Topics
NOVEMBER 27, 2022
Opening a second pharmacy location can be profitable, but isn’t without challenges.
Drug Topics
NOVEMBER 27, 2022
Opening a second pharmacy location can be profitable, but isn’t without challenges.
pharmaphorum
NOVEMBER 27, 2022
A group representing pharma companies selling precision therapies for cancer has called for a change to the way genomic testing is done in Scotland, to make sure patients get access to targeted drugs. The Scottish Precision Medicines Industry Group (SPMIG) – set up by AstraZeneca, Lilly, Novartis and Roche – is calling on NHS Scotland to make genomic testing available for every cancer patient in the country, so they can receive drugs based on the molecular profile of their tumours, if available.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Store News
NOVEMBER 27, 2022
Three of Planet Based Foods’ products are now available in the frozen aisle at 700 Kroger locations across 10 states.
The Checkup by Singlecare
NOVEMBER 27, 2022
Is Mydayis covered by insurance? | How much does Mydayis cost without insurance? | How to get Mydayis without insurance. Mydayis is a brand-name prescription drug used to improve the symptoms of attention deficit hyperactivity disorder (ADHD). The active ingredients in Mydayis are four different types of amphetamine and dextroamphetamine. Each different chemical variant of these amphetamine stimulants is designed to be released into the bloodstream at variable rates for up to 16 hours, so only o
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Store News
NOVEMBER 27, 2022
Retailers saw an 11% increase in day-of Black Friday site traffic, compared to last year, according to a BlueCore Black Friday report.
Hospital Pharmacy Europe
NOVEMBER 27, 2022
A systematic review suggests that eating honey may improve both lipid and glycaemic health markers when consumed as part of a healthy diet. Eating honey leads to an improvement cardiometabolic risk due to favourable changes in glycaemic control and lipid levels according to a systematic review and meta-analysis by Canadian researchers. Honey is a natural product formed from the nectar of flowers by honeybees and has a long history of use for both nutritional needs and its medicinal properties.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharmaceutical Technology
NOVEMBER 27, 2022
Biocytogen Pharmaceuticals and ADC Therapeutics have signed an assessment and option agreement for evaluating antibodies against three tumour targets. Under the deal, ADC Therapeutics will receive a licence from Biocytogen to evaluate the latter’s antibodies against the targets. Additionally, ADC Therapeutics will have an option for licensing chosen antibodies in the future for international development and marketing of antibody-drug conjugates (ADCs). .
Drug Store News
NOVEMBER 27, 2022
Meijer’s donation will support more than 250 Simply Give food pantries across the Midwest to help feed families in the communities it serves this holiday season.
Med Ed 101
NOVEMBER 27, 2022
The Framingham risk score has been the primary method of determining a patient’s 10-year risk of cardiovascular disease. Scores such as this take into account a patient’s specific risk factors including age, gender, systolic blood pressure, total cholesterol, high-density lipoprotein fraction, smoking status, and diabetes status. These scores have been convenient and cheap, as they […].
Drug Store News
NOVEMBER 27, 2022
Tafluprost ophthalmic solution is a prostaglandin analog indicated for reducing elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
pharmaphorum
NOVEMBER 27, 2022
Supply chain issues have been rife in pharmaceuticals for a while, but current socio-economic challenges such as the conflict in Ukraine and the COVID-19 pandemic have led to extended wait times and higher prices for thousands of products. Incidents such as the hormone replacement therapy drug shortage in early 2022 have shown the damaging impact supply chain issues can have on people who depend on these drugs.
Drug Store News
NOVEMBER 27, 2022
Most consumers are now using natural OTCs, mostly because they think natural products are safer and with fewer nasty side effects.
pharmaphorum
NOVEMBER 27, 2022
Jointly Bayer and Orion Corporation-developed NUBEQA (Darolutamide) + Androgen Deprivation Therapy (ADT) in combination with docetaxel is to be the first prostate cancer treatment to be made available by NHS England through an early national access agreement, following accelerated regulatory approval by the Medicines and Healthcare products Regulatory Agency (MHRA) under Project Orbis.
Drug Store News
NOVEMBER 27, 2022
Releuko is used to treat neutropenia which is commonly experienced by patients undergoing chemotherapy.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
BuzzRx
NOVEMBER 27, 2022
The U.S. Food and Drug Administration approved the first female birth control pill in 1960. Within two years, more than 1.2 million American women were using this method of contraception, commonly called “the pill.” In 2022, when a landmark judgment ended the constitutional right to abortion in the United States, inquiries about vasectomies skyrocketed as men stepped up to share the responsibility of contraception and play a more active role in reproductive health along with their female partner
Let's personalize your content